Therapy of Pseudomonas aeruginosa Infections with Tobramycin
The efficacy of tobramycin in doses of 2.7 to 5.6 mg/kg per day in 29 courses of therapy in 25 hospitalized patients with serious Pseudomonas aeruginosa infections was studied. Eighty-three percent of the P. aeruginosa strains showed zones of inhibition of 16 mm or more around a 10-μg tobramycin dis...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1975
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC429254/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/809002/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.8.1.22 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|